🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the producers of Tylenol, asserting the companies withheld safety concerns that the pain reliever presented to children's neurological development.

The lawsuit follows four weeks after Former President Trump promoted an unverified association between consuming acetaminophen - referred to as paracetamol - during pregnancy and autism spectrum disorder in children.

The attorney general is taking legal action against Johnson & Johnson, which previously sold the drug, the exclusive pain medication suggested for pregnant women, and Kenvue, which currently produces it.

In a statement, he stated they "misled consumers by profiting off of discomfort and pushing pills regardless of the risks."

The company says there is no credible evidence tying Tylenol to autism.

"These corporations misled for generations, knowingly endangering millions to increase profits," Paxton, from the Republican party, stated.

The manufacturer commented that it was "seriously troubled by the spread of false claims on the security of acetaminophen and the likely effects that could have on the health of US mothers and children."

On its official site, Kenvue also stated it had "continuously evaluated the relevant science and there is lacking reliable evidence that demonstrates a established connection between using paracetamol and autism."

Groups acting on behalf of medical professionals and health professionals agree.

The American College of Obstetricians and Gynecologists has said acetaminophen - the main ingredient in acetaminophen - is among limited choices for pregnant women to address discomfort and elevated temperature, which can pose serious health risks if ignored.

"In multiple decades of investigation on the utilization of paracetamol in gestation, not a single reputable study has definitively established that the use of acetaminophen in any stage of gestation causes brain development issues in children," the organization stated.

The lawsuit references current declarations from the previous government in arguing the drug is reportedly hazardous.

Last month, Trump generated worry from health experts when he instructed pregnant women to "resist strongly" not to use acetaminophen when ill.

The FDA then issued a notice that doctors should consider limiting the consumption of Tylenol, while also stating that "a proven link" between the drug and autism spectrum disorder in minors has remains unverified.

The Health Department head RFK Jr, who manages the Food and Drug Administration, had pledged in April to initiate "a massive testing and research effort" that would establish the cause of autism in a matter of months.

But experts warned that identifying a sole reason of autism spectrum disorder - believed by scientists to be the outcome of a complicated interplay of genetic and external influences - would prove challenging.

Autism spectrum disorder is a type of enduring cognitive variation and impairment that affects how persons perceive and relate to the surroundings, and is diagnosed using doctors' observations.

In his lawsuit, the attorney general - aligned with the former president who is running for federal office - asserts the manufacturer and Johnson & Johnson "intentionally overlooked and attempted to silence the research" around acetaminophen and autism.

The lawsuit attempts to require the corporations "eliminate any marketing or advertising" that states acetaminophen is safe for women during pregnancy.

This legal action echoes the concerns of a collection of mothers and fathers of minors with autism spectrum disorder and ADHD who sued the makers of Tylenol in 2022.

A federal judge dismissed the case, stating investigations from the plaintiffs' authorities was inconclusive.